Rate of Hepatitis B Virus Infection in Pregnant Women Determined by a Monoclonal Hepatitis B Surface Antigen Immunoassay
Open Access
- 1 September 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (9) , 3493-3496
- https://doi.org/10.1128/jcm.40.9.3493-3496.2002
Abstract
The rate of HBsAg in 6,976 B-human chorionic gonadotropin (B-hCG)-positive specimens, as determined by the Auszyme Monoclonal assay (Abbott Laboratories, Abbott Park, Ill.), was 0.56% (39 of 6,986 repeatedly reactive [RR] and confirmed-positive specimens). All RR and confirmed specimens were hepatitis B virus positive by at least one additional test, yielding an assay specificity of 99.96%. The findings argue against unique attributes in the pregnant population that might produce inaccurate assay results.Keywords
This publication has 8 references indexed in Scilit:
- Human Anti-Animal Antibody Interferences in Immunological AssaysClinical Chemistry, 1999
- Update on Diagnosis, Management, and Prevention of Hepatitis B Virus InfectionClinical Microbiology Reviews, 1999
- Hepatitis B: diagnosis, prevention, and treatmentClinical Chemistry, 1997
- Faulty washers and soiled micropipettors may generate false positive serological resultsClinical and Diagnostic Virology, 1997
- Hepatitis B surface antigenemia in blood donors following vaccinationTransfusion, 1995
- BRIEF SURFACE ANTIGENEMIA IN NEWBORN INFANTS VACCINATED WITH HEPATITIS B VACCINEThe Pediatric Infectious Disease Journal, 1993
- Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP).1991
- Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen.1988